| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;92:926-934.)
© 1995 American Heart Association, Inc.
Articles |
From the Cardiology Division of the Department of Medicine, University of Alberta, Edmonton, Canada.
Background Late reperfusion during acute myocardial infarction results in delayed recovery of ventricular function and less remodeling, whereas ventricular unloading with nitrates improves function and attenuates remodeling. Whether late reperfusion combined with prolonged unloading with isosorbide-5-mononitrate (ISMN) might produce greater functional recovery and less remodeling than late reperfusion alone is not known.
Methods and Results In vivo left ventricular function
and topography (echocardiograms), postmortem topography (planimetry),
and collagen (hydroxyproline) were measured in dogs that were
randomized to reperfusion 2 hours after left anterior descending
coronary artery ligation, and ISMN (n=12) or placebo (n=12) was
given as 25 mg IV over 4 hours followed by 50 mg PO QID for 6 weeks.
Compared with placebo, the ISMN group had similar heart rate but lower
left atrial pressure, mean arterial pressure, and
rate-pressure products. Although in vivo baseline remodeling and
functional parameters were similar in the two groups, by 6
weeks the ISMN group had smaller (P
.05) infarct and
noninfarct segment lengths, ventricular volumes, and mass;
less (P<.001) asynergy; and greater (P<.001)
ejection fraction. More important, by 2 days, ejection fraction was
18% greater (P<.025) and asynergy 26% less
(P<.05) with ISMN. At 6 weeks, ISMN showed less
(P
.05) scar size, scar collagen, cavity dilation,
noninfarct wall thickness, and apical bulging than placebo. In another
4 dogs, acute ISMN produced less improvement in function and remodeling
than prolonged ISMN.
Conclusions Late reperfusion of acute anterior myocardial infarction combined with prolonged ISMN unloading results in greater and earlier recovery of ventricular function and less remodeling than late reperfusion alone.
Key Words: remodeling reperfusion hypertrophy proteins
This article has been cited by other articles:
![]() |
G. Ertl and S. Frantz Healing after myocardial infarction Cardiovasc Res, April 1, 2005; 66(1): 22 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ertl and S. Frantz Wound model of myocardial infarction Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H981 - H983. [Full Text] [PDF] |
||||
![]() |
B. I. Jugdutt and V. Menon Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 217 - 226. [Abstract] [PDF] |
||||
![]() |
B. Meyns, J. Stolinski, V. Leunens, E. Verbeken, and W. Flameng Left ventricular support by Catheter-Mountedaxial flow pump reduces infarct size J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1087 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Jugdutt and V. Menon Beneficial Effects of Therapy on the Progression of Structural Remodeling During Healing After Reperfused and Nonreperfused Myocardial Infarction: Different Effects on Different Parameters Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 95 - 107. [Abstract] [PDF] |
||||
![]() |
B. I. Jugdutt Monocytosis and adverse left ventricular remodeling after reperfused myocardial infarction J. Am. Coll. Cardiol., January 16, 2002; 39(2): 247 - 250. [Full Text] [PDF] |
||||
![]() |
B. I Jugdutt and M. Balghith Enhanced regional AT2-receptor and PKC{varepsilon} expression during cardioprotection induced by AT1-receptor blockade after reperfused myocardial infarction Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 134 - 140. [Abstract] [PDF] |
||||
![]() |
Yi Xu, V. Menon, and B. I Jugdutt Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-{varepsilon} in acutely reperfused myocardial infarction in the dog: Effect of UP269-6 and losartan on AT1- and AT2-receptor expression and IP3 receptor and PKC{varepsilon} proteins Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 184 - 195. [Abstract] [PDF] |
||||
![]() |
B. I. Jugdutt, Yi Xu, M. Balghith, R. Moudgil, and V. Menon Cardioprotection Induced by AT1R Blockade After Reperfused Myocardial Infarction: Association With Regional Increase in AT2R, IP3R and PKC{varepsilon} Proteins and cGMP Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 301 - 311. [Abstract] [PDF] |
||||
![]() |
U. Elkayam, J. V. Johnson, A. Shotan, S. Bokhari, A. Solodky, M. Canetti, O. R. Wani, and I. S. Karaalp Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Organic Nitrates in Patients With Chronic Heart Failure Treated With Angiotensin-Converting Enzyme Inhibition Circulation, May 25, 1999; 99(20): 2652 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Mahmarian, L. A. Moye, D. A. Chinoy, R. F. Sequeira, G. B. Habib, W. J. Henry, A. Jain, B. R. Chaitman, C. S. W. Weng, H. Morales-Ballejo, et al. Transdermal Nitroglycerin Patch Therapy Improves Left Ventricular Function and Prevents Remodeling After Acute Myocardial Infarction : Results of a Multicenter Prospective Randomized, Double-Blind, Placebo-Controlled Trial Circulation, May 26, 1998; 97(20): 2017 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. McDonald, C. Chu, G. Francis, D. Judd, W. Carlyle, C. Toher, K. Hauer, and M. Hartman The effect of delayed reperfusion following infarction in the rat on structural changes in viable myocardium Cardiovasc Res, December 1, 1997; 36(3): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |